- Home
- CRSR vs AVBP Comparison
CRSR vs AVBP Comparison
Compare CRSR & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- AVBP
- Stock Information
- Founded
- CRSR 1994
- AVBP 2021
- Country
- CRSR United States
- AVBP United States
- Employees
- CRSR N/A
- AVBP N/A
- Industry
- CRSR Computer Manufacturing
- AVBP
- Sector
- CRSR Technology
- AVBP
- Exchange
- CRSR Nasdaq
- AVBP NYSE
- Market Cap
- CRSR 958.7M
- AVBP 862.8M
- IPO Year
- CRSR 2020
- AVBP 2024
- Fundamental
- Price
- CRSR $9.32
- AVBP $20.17
- Analyst Decision
- CRSR Buy
- AVBP Strong Buy
- Analyst Count
- CRSR 6
- AVBP 8
- Target Price
- CRSR $10.00
- AVBP $39.00
- AVG Volume (30 Days)
- CRSR 522.9K
- AVBP 475.8K
- Earning Date
- CRSR 07-31-2025
- AVBP 08-13-2025
- Dividend Yield
- CRSR N/A
- AVBP N/A
- EPS Growth
- CRSR N/A
- AVBP N/A
- EPS
- CRSR N/A
- AVBP N/A
- Revenue
- CRSR $1,348,872,000.00
- AVBP N/A
- Revenue This Year
- CRSR $14.40
- AVBP $85.82
- Revenue Next Year
- CRSR $9.76
- AVBP N/A
- P/E Ratio
- CRSR N/A
- AVBP N/A
- Revenue Growth
- CRSR N/A
- AVBP N/A
- 52 Week Low
- CRSR $5.60
- AVBP $15.47
- 52 Week High
- CRSR $13.02
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- CRSR 53.13
- AVBP 36.66
- Support Level
- CRSR $9.28
- AVBP $20.00
- Resistance Level
- CRSR $9.83
- AVBP $23.27
- Average True Range (ATR)
- CRSR 0.35
- AVBP 1.52
- MACD
- CRSR -0.03
- AVBP -0.52
- Stochastic Oscillator
- CRSR 50.72
- AVBP 7.55
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.